Company Overview - Lifeward Ltd is a global market leader in delivering life-changing solutions for rehabilitation, recovery, and enabling individuals with physical limitations or disabilities to pursue their passions [1] - The company designs, develops, and commercializes innovative products across the continuum of care in physical rehabilitation and recovery, including the ReWalk Exoskeleton, AlterG Anti-Gravity System, MyoCycle FES System, and ReStore Exo-Suit [6] - Founded in 2001, Lifeward has operations in the United States, Israel, and Germany [7] Capital Raising Activities - Lifeward closed a registered direct offering of 1,818,183 ordinary shares at $2.75 per share, raising approximately $5.0 million in gross proceeds [1][2] - In a concurrent private placement, the company issued unregistered short-term warrants to purchase up to 1,818,183 ordinary shares, with a three-year term, immediate exercisability, and an exercise price of $2.75 per share [1] - H C Wainwright & Co acted as the exclusive placement agent for the offering [2] - The net proceeds will be used for continuing commercial efforts, working capital, and general corporate purposes [2] Regulatory and Legal Information - The ordinary shares were offered pursuant to a shelf registration statement on Form S-3 (Registration No 333-263984) previously filed with and declared effective by the SEC [3] - The warrants and underlying ordinary shares were issued in a private placement under Section 4(a)(2) of the Securities Act and Regulation D, and are not registered under the Securities Act or applicable state securities laws [4] Business Strategy and Mission - Lifeward's mission is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities [6] - The company is committed to delivering groundbreaking solutions that empower individuals to do what they love [6] - Lifeward's products deliver proven functional and health benefits in clinical settings as well as in the home and community [6]
Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules